🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 10 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/12/2000 | 8,41 | 8,41 | 7,94 | 8,00 | -3,03% | 5,58% | 1.511.400 |
| 11/12/2000 | 7,83 | 8,38 | 7,75 | 8,25 | +3,53% | 7,98% | 1.348.000 |
| 08/12/2000 | 7,75 | 8,13 | 7,69 | 7,97 | +4,94% | 5,65% | 2.000.400 |
| 07/12/2000 | 7,91 | 7,94 | 7,25 | 7,59 | -3,95% | 8,70% | 1.731.800 |
| 06/12/2000 | 8,67 | 8,81 | 7,38 | 7,91 | -5,60% | 16,58% | 1.447.200 |
| 05/12/2000 | 9,02 | 9,38 | 8,13 | 8,38 | -6,62% | 13,86% | 2.847.400 |
| 04/12/2000 | 11,97 | 12,13 | 8,00 | 8,97 | -62,34% | 34,46% | 14.154.800 |
| 01/12/2000 | 22,78 | 24,28 | 22,78 | 23,81 | -1,68% | 6,58% | 1.087.600 |
| 30/11/2000 | 22,19 | 24,25 | 20,56 | 24,22 | +8,09% | 16,62% | 820.200 |
| 29/11/2000 | 23,84 | 24,19 | 22,19 | 22,41 | -4,65% | 8,39% | 531.200 |
| 28/11/2000 | 26,00 | 26,00 | 23,44 | 23,50 | -7,84% | 9,86% | 82.000 |
| 27/11/2000 | 25,98 | 26,06 | 25,09 | 25,50 | +1,75% | 3,73% | 193.400 |
| 24/11/2000 | 23,56 | 25,50 | 23,56 | 25,06 | +6,37% | 8,22% | 251.800 |
| 22/11/2000 | 22,75 | 24,22 | 22,50 | 23,56 | -0,79% | 7,56% | 309.000 |
| 21/11/2000 | 22,75 | 24,44 | 22,75 | 23,75 | +4,25% | 7,42% | 568.000 |
| 20/11/2000 | 25,31 | 25,47 | 22,78 | 22,78 | -10,88% | 10,62% | 306.200 |
| 17/11/2000 | 27,25 | 29,00 | 25,34 | 25,56 | -5,32% | 13,42% | 233.400 |
| 16/11/2000 | 28,59 | 29,75 | 26,13 | 27,00 | -6,90% | 12,68% | 405.400 |
| 15/11/2000 | 30,84 | 30,88 | 29,00 | 29,00 | -3,08% | 6,08% | 618.600 |
| 14/11/2000 | 30,00 | 32,00 | 29,84 | 29,92 | +1,43% | 7,19% | 675.200 |
| 13/11/2000 | 31,00 | 31,00 | 28,38 | 29,50 | -6,53% | 8,47% | 1.269.800 |
| 10/11/2000 | 31,56 | 33,59 | 31,50 | 31,56 | -5,67% | 6,63% | 252.200 |
| 09/11/2000 | 34,88 | 34,88 | 32,50 | 33,46 | -4,05% | 6,83% | 624.200 |
| 08/11/2000 | 35,56 | 35,56 | 34,69 | 34,88 | -0,36% | 2,46% | 120.200 |
| 07/11/2000 | 35,66 | 35,68 | 34,25 | 35,00 | +0,00% | 4,01% | 253.200 |
| 06/11/2000 | 35,25 | 36,38 | 34,69 | 35,00 | -1,41% | 4,79% | 351.600 |
| 03/11/2000 | 32,50 | 36,34 | 32,50 | 35,50 | +7,58% | 11,83% | 1.391.200 |
| 02/11/2000 | 30,46 | 36,00 | 28,75 | 33,00 | +16,30% | 23,80% | 1.033.000 |
| 01/11/2000 | 26,78 | 28,50 | 26,44 | 28,38 | +6,07% | 7,70% | 710.000 |
| 31/10/2000 | 24,91 | 28,63 | 24,81 | 26,75 | +7,13% | 15,30% | 1.392.600 |